Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 1 SUPPL. 52, 2009, Pages

  Boiardi, Luigi ^a   Casali, Bruno ^a   Farnetti, Enrico ^a   Pipitone, Nicolò ^a   Nicoli, Davide ^a   Macchioni, PierLuigi ^a   Cimino, Luca ^b   Bajocchi, Gian Luigi ^a   Catanoso, Maria Grazia ^a   Pattacini, Laura ^a   Ghinoi, Alessandra ^a   Restuccia, Giovanna ^a   Salvarani, Carlo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b Unita Operativa di Reumatologia   (Italy)

Author keywords

Giant cell arteritis; Ischemic complications; Toll like receptor 4; Toll like receptor 4 polymorphisms

Indexed keywords

PREDNISONE; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; BLOOD VESSEL BIOPSY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; ISCHEMIA; ISCHEMIC OPTIC NEUROPATHY; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL IMPAIRMENT;

EID: 70350162305     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. SALVARANI C, CANTINI F, HUNDER GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372: 234-245
2. GONZÁLEZ-GAY MA, GARCÍA-PORRÚA C: Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 7 29-49.
3. BAS-LANDO M, BREUER GS, BERKUN Y, MATES M, SONNENBLICK M, NESHER G: The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S15-7.
4. LOPEZ-DIAZ MJ, LLORCA J, GONZALEZ-JUANATEY C, PEÑA-SAGREDO JL, MARTIN J, GONZALEZ-GAY MA: Implication of the age in the clinical spectrum of giant cell arteritis. Clin Exp Rheumatol 2008; 26 (Suppl. 49): S16-22.
5. WEYAND CM, GORONZY JJ: Medium- and large-vessel vasculitis. N Engl J Med 2003; 349: 160-169
6. MA-KRUPA W, JEON MS, SPOERL S, TEDDER TF, GORONZY JJ, WEYAND CM: Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004; 199: 173-183
7. MA-KRUPA W, KWAN M, GORONZY JJ, WEYAND CM: Toll-like receptors in giant cell arteritis. Clin Immunol 2005; 115: 38-46.
8. GONZALEZ-GAY MA, AMOLI MM, GARCIA-PORRUA C, OLLIER WE: Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003; 33: 38-48.
9. ARBOUR NC, LORENZ E, SCHUTTE BC et al.: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191
10. BROWNING BL, HUEBNER C, PETERMANN I et al.: Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007; 102: 2504-2512
11. SNELGROVE T, LIM S, GREENWOOD C, PEDDLE L et al.: Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol 2007; 34: 368-370 (Pubitemid 46255756)
12. ADAM R, STURROCK RD, GRACIE JA: TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis. Ann Rheum Dis 2006; 65: 1099-1101
13. LAMB R, ZEGGINI E, THOMSON W, DONN R: Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Ann Rheum Dis 2005; 64: 767-769 (Pubitemid 40559307)
14. RADSTAKE TR, FRANKE B, HANSSEN S et al.: The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004; 50: 999-1001.
15. SÁNCHEZ E, OROZCO G, LÓPEZ-NEVOT MA, JIMÉNEZ-ALONSO J, MARTÍN J: Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54-57
16. PABST S, BAUMGARTEN G, STREMMEL A et al.: Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143: 420-426
17. REINDL M, LUTTEROTTI A, INGRAM J et al.: Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 2003; 61: 85-88 (Pubitemid 36286753)
18. SCHRÖDER NW, SCHUMANN RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5: 156-164
19. GONZALEZ-GAY MA, BOIARDI L, GARCIA-PORRUA C et al.: Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern Europe. J Rheumatol 2004; 31: 520-523
20. SALVARANI C, MACCHIONI PL, TARTONI PL et al.: Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987; 5: 205-215
21. nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 1989; 9-17.
22. LORENZ E, SCHWARTZ DA, MARTIN PJ et al.: Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 384-387 (Pubitemid 32799056)
23. FERWERDA B, MCCALL MB, VERHEIJEN K et al.: Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 2008; 14: 346-352
24. ROELOFS MF, ABDOLLAHI-ROODSAZ S, JOOSTEN LA, VAN DEN BERG WB, RADSTAKE TR: The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 2008; 58: 338-348
25. SCHNARE M, ROLLINGHOFF M, QURESHI S: Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 2006; 139: 75-85.
26. FRANTZ S, ERTL G, BAUERSACHS J: Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007; 4: 444-454 (Pubitemid 47180328)
27. PAPADIMITRAKI ED, BERTSIAS GK, BOUMPAS DT: Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 2007; 29: 310-318
28. HONG J, LEUNG E, FRASER AG, MERRIMAN TR, VISHNU P, KRISSANSEN GW: TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol 2007; 22: 1760-1766 (Pubitemid 47525075)
29. MINORETTI P, GAZZARUSO C, VITO CD et al.: Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 2006; 391: 147-149
30. KIECHL S, LORENZ E, REINDL M et al.: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347: 185-192
31. NA KS, KIM TH, RAHMAN P, PEDDLE L, CHOI CB, INMAN RD: Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population. Rheumatol Int 2008; 28: 627-630
32. VAN DER PAARDT M, CRUSIUS JB, DE KONING MH et al.: No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann Rheum Dis 2005; 64: 235-238
33. GERGELY P JR, BLAZSEK A, WEISZHÁR Z, PAZÁR B, POÓR G: Lack of genetic association of the Toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondylarthropathies in a Hungarian population. Rheumatology (Oxford) 2006; 45: 1194-1196
34. KILDING R, AKIL M, TILL S et al.: A bio logically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 340-342